Mohammad Rashidian, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oximes | 5 | 2015 | 311 | 1.030 |
Why?
|
Staining and Labeling | 5 | 2015 | 1100 | 1.030 |
Why?
|
Alkyl and Aryl Transferases | 5 | 2022 | 89 | 0.990 |
Why?
|
Aminoacyltransferases | 2 | 2021 | 51 | 0.920 |
Why?
|
Positron-Emission Tomography | 10 | 2022 | 6234 | 0.910 |
Why?
|
Molecular Imaging | 3 | 2021 | 828 | 0.910 |
Why?
|
Pemphigus | 2 | 2021 | 103 | 0.890 |
Why?
|
Immunologic Techniques | 1 | 2021 | 218 | 0.760 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.680 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2020 | 4479 | 0.640 |
Why?
|
Aldehydes | 4 | 2022 | 167 | 0.630 |
Why?
|
Lymphopenia | 1 | 2020 | 285 | 0.620 |
Why?
|
Immobilized Proteins | 3 | 2015 | 25 | 0.590 |
Why?
|
Polyisoprenyl Phosphates | 2 | 2013 | 36 | 0.580 |
Why?
|
Hydrazones | 3 | 2015 | 102 | 0.560 |
Why?
|
Phenylenediamines | 2 | 2015 | 90 | 0.550 |
Why?
|
Enzymes | 2 | 2013 | 266 | 0.500 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2017 | 520 | 0.490 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1276 | 0.470 |
Why?
|
Green Fluorescent Proteins | 3 | 2015 | 2088 | 0.470 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 2013 | 77 | 0.460 |
Why?
|
Sesquiterpenes | 2 | 2013 | 177 | 0.460 |
Why?
|
Tumor Microenvironment | 7 | 2022 | 3586 | 0.430 |
Why?
|
Immunotherapy | 7 | 2022 | 4445 | 0.430 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1988 | 0.390 |
Why?
|
Protein Prenylation | 4 | 2015 | 73 | 0.360 |
Why?
|
Immune System | 1 | 2015 | 805 | 0.350 |
Why?
|
Aspartame | 1 | 2008 | 18 | 0.330 |
Why?
|
Melanoma, Experimental | 4 | 2021 | 561 | 0.320 |
Why?
|
Neoplasms | 8 | 2022 | 21683 | 0.320 |
Why?
|
Copper | 1 | 2010 | 366 | 0.310 |
Why?
|
Immunoglobulin Fragments | 2 | 2018 | 84 | 0.310 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3507 | 0.300 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3703 | 0.290 |
Why?
|
Sweetening Agents | 1 | 2008 | 296 | 0.270 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2020 | 713 | 0.240 |
Why?
|
Terpenes | 2 | 2015 | 98 | 0.230 |
Why?
|
Papillomaviridae | 2 | 2020 | 1119 | 0.220 |
Why?
|
Ankyrin Repeat | 1 | 2022 | 17 | 0.220 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2017 | 1475 | 0.220 |
Why?
|
Proteins | 3 | 2022 | 6103 | 0.210 |
Why?
|
Neoplasm Transplantation | 2 | 2017 | 2085 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Acute Generalized Exanthematous Pustulosis | 1 | 2021 | 13 | 0.200 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.200 |
Why?
|
Gold | 2 | 2022 | 484 | 0.200 |
Why?
|
Monitoring, Immunologic | 1 | 2021 | 100 | 0.200 |
Why?
|
Histological Techniques | 1 | 2021 | 198 | 0.190 |
Why?
|
Cytokines | 3 | 2021 | 7322 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2021 | 4386 | 0.180 |
Why?
|
Mice | 14 | 2021 | 81183 | 0.180 |
Why?
|
Spectrum Analysis, Raman | 1 | 2022 | 247 | 0.170 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6773 | 0.170 |
Why?
|
Polyethylene Glycols | 3 | 2015 | 1182 | 0.170 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2021 | 214 | 0.170 |
Why?
|
Animals | 21 | 2022 | 168757 | 0.170 |
Why?
|
Models, Molecular | 4 | 2015 | 5456 | 0.160 |
Why?
|
Peptides | 1 | 2010 | 4409 | 0.160 |
Why?
|
Metal Nanoparticles | 1 | 2022 | 405 | 0.160 |
Why?
|
Orthomyxoviridae Infections | 1 | 2020 | 248 | 0.160 |
Why?
|
Influenza A virus | 1 | 2020 | 456 | 0.140 |
Why?
|
Radionuclide Imaging | 1 | 2021 | 2031 | 0.140 |
Why?
|
Adipocytes, Brown | 1 | 2017 | 144 | 0.140 |
Why?
|
Substrate Specificity | 4 | 2015 | 1801 | 0.140 |
Why?
|
Glucose | 1 | 2008 | 4397 | 0.140 |
Why?
|
Antigens | 2 | 2020 | 1466 | 0.140 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2018 | 279 | 0.140 |
Why?
|
Organ Specificity | 1 | 2021 | 2008 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.130 |
Why?
|
Freund's Adjuvant | 1 | 2015 | 139 | 0.130 |
Why?
|
Catalysis | 2 | 2015 | 761 | 0.130 |
Why?
|
Copper Radioisotopes | 1 | 2015 | 86 | 0.130 |
Why?
|
Nanotechnology | 1 | 2020 | 710 | 0.130 |
Why?
|
Half-Life | 1 | 2015 | 661 | 0.120 |
Why?
|
Mice, Inbred C57BL | 8 | 2021 | 21827 | 0.120 |
Why?
|
Immunity | 1 | 2020 | 1012 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 349 | 0.120 |
Why?
|
Indicators and Reagents | 1 | 2015 | 462 | 0.120 |
Why?
|
Dimerization | 1 | 2015 | 893 | 0.120 |
Why?
|
Cell Line, Tumor | 5 | 2022 | 16689 | 0.110 |
Why?
|
Luminescent Proteins | 1 | 2015 | 853 | 0.110 |
Why?
|
Cell Extracts | 1 | 2013 | 138 | 0.110 |
Why?
|
Cysteine Endopeptidases | 1 | 2015 | 563 | 0.110 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2015 | 659 | 0.100 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2012 | 59 | 0.100 |
Why?
|
Fluorine Radioisotopes | 1 | 2015 | 442 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2133 | 0.100 |
Why?
|
Bone Marrow Cells | 2 | 2020 | 2513 | 0.100 |
Why?
|
Adipose Tissue, Brown | 1 | 2017 | 757 | 0.100 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1741 | 0.100 |
Why?
|
Hydrazines | 1 | 2013 | 226 | 0.100 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5256 | 0.090 |
Why?
|
Azides | 1 | 2010 | 116 | 0.090 |
Why?
|
Myeloid Cells | 1 | 2015 | 810 | 0.090 |
Why?
|
Biocatalysis | 1 | 2010 | 167 | 0.090 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2012 | 401 | 0.090 |
Why?
|
Alkynes | 1 | 2010 | 306 | 0.090 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 276 | 0.090 |
Why?
|
Molecular Structure | 1 | 2013 | 1899 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1634 | 0.080 |
Why?
|
Flow Cytometry | 2 | 2017 | 5974 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4665 | 0.070 |
Why?
|
Thermodynamics | 1 | 2008 | 596 | 0.070 |
Why?
|
Humans | 18 | 2022 | 744343 | 0.070 |
Why?
|
Antibodies | 1 | 2015 | 2460 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1587 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5655 | 0.070 |
Why?
|
Escherichia coli | 2 | 2022 | 4217 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1990 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2017 | 2958 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 2957 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10180 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2021 | 14557 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2020 | 20822 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5510 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18029 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3848 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13815 | 0.050 |
Why?
|
Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2020 | 19 | 0.050 |
Why?
|
Single-Chain Antibodies | 1 | 2021 | 108 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18111 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 307 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2015 | 19229 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
Female | 9 | 2021 | 380194 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 973 | 0.040 |
Why?
|
Camelids, New World | 1 | 2017 | 20 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2645 | 0.040 |
Why?
|
Primates | 1 | 2020 | 545 | 0.040 |
Why?
|
Signal Transduction | 1 | 2020 | 23403 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4560 | 0.040 |
Why?
|
Proteomics | 1 | 2010 | 3638 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 2018 | 362 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2327 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2020 | 638 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10638 | 0.030 |
Why?
|
Computer Simulation | 1 | 2008 | 6196 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2020 | 4320 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1348 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 16718 | 0.030 |
Why?
|
Biochemistry | 1 | 2015 | 113 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2020 | 1366 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2021 | 1322 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2571 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1256 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2505 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9274 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2020 | 1881 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 2029 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13695 | 0.030 |
Why?
|
Cholesterol | 1 | 2020 | 2917 | 0.020 |
Why?
|
Nanoparticles | 1 | 2022 | 1905 | 0.020 |
Why?
|
Quantum Theory | 1 | 2010 | 70 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 63114 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1023 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 279 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5179 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6386 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2010 | 698 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3386 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5882 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.020 |
Why?
|
Apoptosis | 1 | 2022 | 9727 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9386 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1917 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10481 | 0.020 |
Why?
|
HeLa Cells | 1 | 2010 | 3128 | 0.010 |
Why?
|
HIV-1 | 1 | 2021 | 6939 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12072 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9856 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9583 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19905 | 0.010 |
Why?
|
Rats | 1 | 2015 | 24260 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11124 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15997 | 0.010 |
Why?
|
Male | 2 | 2019 | 350118 | 0.010 |
Why?
|